According to GlobalData’s Drugs Database, the schizophrenia market remains dominated by dopamine-targeted mechanisms, such as ...

"Amphetamines belong to a class of drugs called sympathomimetic amines or stimulants that cause the release of excitatory neurotransmitters, such as dopamine ... to the mood-enhancing properties ...